Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2288
  • Dowloads 108

Original Research

Open Access

Enlarged Virchow’s node as an initial complaint of serous ovarian adenocarcinoma

  • M. Rahman1
  • K. Nakayama1
  • M.T. Rahman1
  • H. Katagiri1
  • T. Ishibashi1
  • K. Miyazaki1,*,

1Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Japan

DOI: 10.12892/ejgo201205546 Vol.33,Issue 5,September 2012 pp.546-548

Published: 10 September 2012

*Corresponding Author(s): K. Miyazaki E-mail: kn88@med.shimane-u.ac.jp

PDF (725.82 kB) View Full-text

Abstract

Background: An enlarged Virchow's node or left supraclavicular lymph node is a classic precursor to the diagnosis of metastatic cancer, usually originating from an abdominal organ. It is rarely found in ovarian carcinoma. Case report: A 49-year-old woman presented a painless mass in her left supraclavicular fossa. A histopathological examination of the same mass was consistent with a serous adenocarcinoma of ovarian origin. The patient was initially asymptomatic, even with the disease in an advanced stage. Left supraclavicular adenopathy has not been previously reported as a presenting complaint of ovarian carcinoma. Conclusion: Ovarian carcinoma in contemporary with a Virchow's node is an isolated finding.

Keywords

Virchow’s metastasis; Ovarian carcinoma

Cite and Share

M. Rahman, K. Nakayama, M.t. Rahman, H. Katagiri, T. Ishibashi, K. Miyazaki. Enlarged Virchow’s node as an initial complaint of serous ovarian adenocarcinoma. European Journal of Gynaecological Oncology. 2012; 33(5): 546-548. doi: 10.12892/ejgo201205546

URL:

https://www.ejgo.net/articles/10.12892/ejgo201205546

References

[1] Goff B.A., Mandel L.S., Melancon C.H., Muntz H.G.: “Frequency of symptoms of ovarian cancer in women presenting to primary care clinics”. JAMA, 2004, 291, 2705.

[2] Takeshima N., Hirai Y., Umayahara K., Fujiwara K., Takizawa K., Hasumi K.: “Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors”. Gynecol. Oncol., 2005, 99, 427.

[3] Morgenstern L.: “The Virchow-Troisier node: a historical note”. Am. J. Surg., 1979, 138, 703.

[4] Virchow R.: “Zur Diagnose der Krebse in Unterleibe”. Med. Reform., 1848, 45, 248.

[5] Troisier C.E.: “L’adénopathie sus-claviculaire dans les cancers de l’abdomen”. Arch. Gen. de Med., 1889, 1, 129, 297.

[6] Mizutani M., Nawata S., Hirai I., Murakami G., Kimura W.: “Anatomy and histology of Virchow’s node”. Anat. Sci Int., 2005, 80, 193.

[7] Seidman J.D., Horkayne-Szakaly I., Haiba M., Boice C.R., Kurman R.J., Ronnett B.M.: “The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin”. Int. J. Gynecol. Pathol., 2004, 23, 41.

[8] Zannoni G.F., Vellone V.G., Distefano M.G., Fadda G., Scambia G.: “Ovarian serous carcinoma presenting with mediastinal lymphadenopathy 20 months before the intraabdominal mass: role of immunohistochemistry”. Gynecol. Oncol., 2007, 104, 497.

[9] Lee K.R., Tavassoli F.A., Pratt J., Dietel M., Gersell D.J., Karseladze A.I.: “Tumors of the ovary and peritoneum (surface epithelial-stromal tumors)”. In: Tavassoli F., Devilee P. (eds.). World Health Organization Classification of Tumors, Geneva, 2003, 117.

[10] Cannistra S.A.: “Cancer of the ovary”. N. Engl. J. Med., 2004, 351, 2519.

Submission Turnaround Time

Top